IntroductionParaneoplastic dermatomyositis is a well-recognised clinical entity, and should prompt investigation for an underlying malignancy. Immunosuppressive treatment can be effective in control of both skin and muscle disease. The effect of checkpoint inhibitors for control of solid tumours on autoimmune paraneoplastic phenomena is yet to be fully understood.
展开▼